Jim Cramer Was Right About These 5 Stocks

3. Merck & Co Inc (NYSE:MRK)

Number of Hedge Fund Investors: 98

Cramer’s Recommendation: Buy

YTD Performance in 2024: +13%

Jim Cramer praised Merck & Co Inc (NYSE:MRK) shares in October 2023 when he was asked about his thoughts on the healthcare company. Back in the summer of 2023 Cramer had said that Merck & Co Inc (NYSE:MRK) was doing a “terrific job” at reinventing itself. Merck & Co Inc (NYSE:MRK) shares have gained about 14% in 2024 through February 26.

As of the end of the fourth quarter of 2023, 98 hedge funds tracked by Insider Monkey had stakes in Merck & Co Inc (NYSE:MRK).

Carillon Eagle Mid Cap Growth Fund made the following comment about Merck & Co., Inc. (NYSE:MRK) in its Q3 2023 investor letter:

“Merck & Co., Inc. (NYSE:MRK) underperformed in the third quarter, based on what we view as largely macroeconomic-related factors. The company continues to execute well, both clinically and fundamentally, but much of the biopharmaceutical industry has been weak as investors are gravitating to other, more cyclical sectors.”